信息技术支持的患者招募有效性:德国十所大学医院间断时间序列研究的研究方案
该研究方案采用间断时间序列设计,在德国十所大学医院评估MIRACUM项目开发的IT招募工具对临床试验招募人数的影响,并测量组织负担与用户满意度。研究持续15个月,试验先进入随机长度的对照期,再进入IT支持的干预期,主要结局为标准化每周每试验招募人数,计划纳入100项试验(每中心10项)。
要点
- 采用间断时间序列设计,在十所德国大学医院评估IT招募工具对招募人数的影响。
- 主要结局为按目标每周招募人数和预期招募时长标准化的每试验每周招募人数。
- 计划纳入100项试验(每中心10项),样本量计算基于平行组假设可检测d=0.57的效应量。
核心结论
- MIRACUM联盟开发的IT支持招募方案可增加德国大学医院的研究招募参与者数量,并支持参与试验招募的员工且易于融入日常工作。
研究设计与样本
- 采用间断时间序列设计,持续时间15个月,在十所德国大学医院开展。
- 所有试验以随机长度的对照期开始,期间进行常规招募,随后转入干预期并附加IT支持。
- 干预措施为应用招募支持系统,该系统利用常规医疗中收集的患者数据按特定标准进行筛选。
- 所有入选试验的纳入和排除标准使用OHDSI ATLAS工具转换为机器可读格式,并定期将数据集成中心的患者数据与这些标准进行比对。
- 样本量计算基于简单平行组假设,在显著性水平5%和80%把握度下,总样本100项试验(每中心10项)可检测效应量d=0.57。
主要发现
- 主要结局为每项试验每周招募的参与者数量,按该试验的目标每周参与者数量和预期招募时长进行标准化。
- 次要结局为招募支持系统的可用性、有用性和有效性。
- 主要分析将使用线性混合模型,以每周每试验实际招募人数按预期每周每试验招募人数标准化后作为因变量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As part of the German Medical Informatics Initiative, the MIRACUM project establishes data integration centers across ten German university hospitals. The embedded MIRACUM Use Case "Alerting in Care - IT Support for Patient Recruitment", aims to support the recruitment into clinical trials by automatically querying the repositories for patients satisfying eligibility criteria and presenting them as screening candidates. The objective of this study is to investigate whether the developed recruitment tool has a positive effect on study recruitment within a multi-center environment by increasing the number of participants. Its secondary objective is the measurement of organizational burden and user satisfaction of the provided IT solution. METHODS: The study uses an Interrupted Time Series Design with a duration of 15 months. All trials start in the control phase of randomized length with regular recruitment and change to the intervention phase with additional IT support. The intervention consists of the application of a recruitment-support system which uses patient data collected in general care for screening according to specific criteria. The inclusion and exclusion criteria of all selected trials are translated into a machine-readable format using the OHDSI ATLAS tool. All patient data from the data integration centers is regularly checked against these criteria. The primary outcome is the number of participants recruited per trial and week standardized by the targeted number of participants per week and the expected recruitment duration of the specific trial. Secondary outcomes are usability, usefulness, and efficacy of the recruitment support. Sample size calculation based on simple parallel group assumption can demonstrate an effect size of d=0.57 on a significance level of 5% and a power of 80% with a total number of 100 trials (10 per site). Data describing the included trials and the recruitment process is collected at each site. The primary analysis will be conducted using linear mixed models with the actual recruitment number per week and trial standardized by the expected recruitment number per week and trial as the dependent variable. DISCUSSION: The application of an IT-supported recruitment solution developed in the MIRACUM consortium leads to an increased number of recruited participants in studies at German university hospitals. It supports employees engaged in the recruitment of trial participants and is easy to integrate in their daily work.
引用
- Boeker M, Zöller D, Blasini R, et al. Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals. Trials. 2024. PMID: 38365848. doi:10.1186/s13063-024-07918-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。